ANDREW GEMMELL: Open Payments
NPI 1952082752 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 37 payments from 6 companies in 2025. Trend: 2023 $89 · 2024 $277 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $507 |
| Novo Nordisk Inc | 3 | $58 |
| Madrigal Pharmaceuticals | 1 | $49 |
| Janssen Biotech, Inc. | 2 | $43 |
| PFIZER INC. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: RINVOQ, LINZESS, Wegovy, REZDIFFRA, SKYRIZI, TREMFYA, VELSIPITY, EOHILIA.
Industry payments across PA — which companies pay providers there.
